Europe Genomics In Cancer Care Market Size, Share & Trends Analysis Report By Application, By Product (Instruments, Consumables, Services), By Technology, By Country and Growth Forecast, 2024 - 2031
The Europe Genomics In Cancer Care Market would witness market growth of 15.5% CAGR during the forecast period (2024-2031).
The Germany market dominated the Europe Genomics In Cancer Care Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $3,939.1 million by 2031. The UK market is exhibiting a CAGR of 14.5% during (2024 - 2031). Additionally, The France market would experience a CAGR of 16.4% during (2024 - 2031).
Genomic information allows for the personalization of chemotherapy regimens based on the genetic profile of the patient and the tumor. By identifying genetic variations that affect drug metabolism and efficacy, clinicians can tailor chemotherapy protocols to improve treatment effectiveness and reduce adverse effects, ensuring that each patient receives the most appropriate drugs.
Additionally, adoption of genomics in cancer care has significantly transformed the oncology landscape, driven personalized treatment approaches, and improved patient outcomes. Genomics is increasingly integrated into standard clinical practice as part of routine cancer care.
The high cancer rates in Europe lead to increased government funding and support for cancer research programs. European governments allocate more resources towards genomic research initiatives to understand cancer genomics and develop new treatments. Among the EU countries, the share of deaths from cancer in the total number of deaths in 2021 reached or exceeded 26.0 % in Denmark (28.2 %), Ireland (27.7 %), Slovenia (27.1 %) and the Netherlands (26.6 %). This share peaked at 30.7 % among males in Slovenia, followed by 29.5 % in Denmark.
Based on Application, the market is segmented into Diagnostics, Personalized Medicine, Drug Discovery & Development, and Research. Based on Product, the market is segmented into Instruments, Consumables, Services. Based on Technology, the market is segmented into PCR, Genome Sequencing, Microarrays, Nuclei Acid Extraction & Purification, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
List of Key Companies Profiled
- Agilent Technologies, Inc.
- F. Hoffmann-La Roche Ltd.
- Danaher Corporation (Beckman Coulter, Inc.)
- Abbott Laboratories
- Bio-Rad Laboratories, Inc.
- GE HealthCare Technologies, Inc.
- Quest Diagnostics Incorporated
- Revvity, Inc.
- Eurofins Scientific SE
- Hologic, Inc.
By Application
- Diagnostics
- Personalized Medicine
- Drug Discovery & Development
- Research
- Instruments
- Consumables
- Services
- PCR
- Genome Sequencing
- Microarrays
- Nuclei Acid Extraction & Purification
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
- Chapter 1. Market Scope & Methodology
- 1.1 Market Definition
- 1.2 Objectives
- 1.3 Market Scope
- 1.4 Segmentation
- 1.4.1 Europe Genomics In Cancer Care Market, by Application
- 1.4.2 Europe Genomics In Cancer Care Market, by Product
- 1.4.3 Europe Genomics In Cancer Care Market, by Technology
- 1.4.4 Europe Genomics In Cancer Care Market, by Country
- 1.5 Methodology for the research
- Chapter 2. Market at a Glance
- 2.1 Key Highlights
- Chapter 3. Market Overview
- 3.1 Introduction
- 3.1.1 Overview
- 3.1.1.1 Market Composition and Scenario
- 3.2 Key Factors Impacting the Market
- 3.2.1 Market Drivers
- 3.2.2 Market Restraints
- 3.2.3 Market Opportunities
- 3.2.4 Market Challenges
- Chapter 4. Competition Analysis - Global
- 4.1 KBV Cardinal Matrix
- 4.2 Recent Industry Wide Strategic Developments
- 4.2.1 Partnerships, Collaborations and Agreements
- 4.2.2 Product Launches and Product Expansions
- 4.2.3 Acquisition and Mergers
- 4.3 Market Share Analysis, 2023
- 4.4 Top Winning Strategies
- 4.4.1 Key Leading Strategies: Percentage Distribution (2020-2024)
- 4.4.2 Key Strategic Move: (Mergers and Acquisitions: 2021, Jan – 2023, Jan) Leading Players
- 4.5 Porter Five Forces Analysis
- Chapter 5. Europe Genomics In Cancer Care Market by Application
- 5.1 Europe Diagnostics Market by Country
- 5.2 Europe Personalized Medicine Market by Country
- 5.3 Europe Drug Discovery & Development Market by Country
- 5.4 Europe Research Market by Country
- Chapter 6. Europe Genomics In Cancer Care Market by Product
- 6.1 Europe Instruments Market by Country
- 6.2 Europe Consumables Market by Country
- 6.3 Europe Services Market by Country
- Chapter 7. Europe Genomics In Cancer Care Market by Technology
- 7.1 Europe PCR Market by Country
- 7.2 Europe Genome Sequencing Market by Country
- 7.3 Europe Microarrays Market by Country
- 7.4 Europe Nuclei Acid Extraction & Purification Market by Country
- 7.5 Europe Others Market by Country
- Chapter 8. Europe Genomics In Cancer Care Market by Country
- 8.1 Germany Genomics In Cancer Care Market
- 8.1.1 Germany Genomics In Cancer Care Market by Application
- 8.1.2 Germany Genomics In Cancer Care Market by Product
- 8.1.3 Germany Genomics In Cancer Care Market by Technology
- 8.2 UK Genomics In Cancer Care Market
- 8.2.1 UK Genomics In Cancer Care Market by Application
- 8.2.2 UK Genomics In Cancer Care Market by Product
- 8.2.3 UK Genomics In Cancer Care Market by Technology
- 8.3 France Genomics In Cancer Care Market
- 8.3.1 France Genomics In Cancer Care Market by Application
- 8.3.2 France Genomics In Cancer Care Market by Product
- 8.3.3 France Genomics In Cancer Care Market by Technology
- 8.4 Russia Genomics In Cancer Care Market
- 8.4.1 Russia Genomics In Cancer Care Market by Application
- 8.4.2 Russia Genomics In Cancer Care Market by Product
- 8.4.3 Russia Genomics In Cancer Care Market by Technology
- 8.5 Spain Genomics In Cancer Care Market
- 8.5.1 Spain Genomics In Cancer Care Market by Application
- 8.5.2 Spain Genomics In Cancer Care Market by Product
- 8.5.3 Spain Genomics In Cancer Care Market by Technology
- 8.6 Italy Genomics In Cancer Care Market
- 8.6.1 Italy Genomics In Cancer Care Market by Application
- 8.6.2 Italy Genomics In Cancer Care Market by Product
- 8.6.3 Italy Genomics In Cancer Care Market by Technology
- 8.7 Rest of Europe Genomics In Cancer Care Market
- 8.7.1 Rest of Europe Genomics In Cancer Care Market by Application
- 8.7.2 Rest of Europe Genomics In Cancer Care Market by Product
- 8.7.3 Rest of Europe Genomics In Cancer Care Market by Technology
- Chapter 9. Company Profiles
- 9.1 Agilent Technologies, Inc.
- 9.1.1 Company Overview
- 9.1.2 Financial Analysis
- 9.1.3 Segmental and Regional Analysis
- 9.1.4 Research & Development Expense
- 9.1.5 Recent strategies and developments:
- 9.1.5.1 Acquisition and Mergers:
- 9.1.6 SWOT Analysis
- 9.2 F. Hoffmann-La Roche Ltd.
- 9.2.1 Company Overview
- 9.2.2 Financial Analysis
- 9.2.3 Segmental and Regional Analysis
- 9.2.4 Research & Development Expense
- 9.2.5 Recent strategies and developments:
- 9.2.5.1 Partnerships, Collaborations, and Agreements:
- 9.2.5.2 Product Launches and Product Expansions:
- 9.2.6 SWOT Analysis
- 9.3 Danaher Corporation (Beckman Coulter, Inc.)
- 9.3.1 Company Overview
- 9.3.2 Financial Analysis
- 9.3.3 Segmental and Regional Analysis
- 9.3.4 Research & Development Expense
- 9.3.5 Recent strategies and developments:
- 9.3.5.1 Partnerships, Collaborations, and Agreements:
- 9.3.6 SWOT Analysis
- 9.4 Abbott Laboratories
- 9.4.1 Company Overview
- 9.4.2 Financial Analysis
- 9.4.3 Segmental and Regional Analysis
- 9.4.4 Research & Development Expense
- 9.4.5 SWOT Analysis
- 9.5 Bio-Rad laboratories, Inc.
- 9.5.1 Company Overview
- 9.5.2 Financial Analysis
- 9.5.3 Segmental and Regional Analysis
- 9.5.4 Research & Development Expenses
- 9.5.5 Recent strategies and developments:
- 9.5.5.1 Partnerships, Collaborations, and Agreements:
- 9.5.5.2 Product Launches and Product Expansions:
- 9.5.6 SWOT Analysis
- 9.6 GE HealthCare Technologies, Inc.
- 9.6.1 Company Overview
- 9.6.2 Financial Analysis
- 9.6.3 Segmental and Regional Analysis
- 9.6.4 Research & Development Expenses
- 9.6.5 Recent strategies and developments:
- 9.6.5.1 Partnerships, Collaborations, and Agreements:
- 9.6.6 SWOT Analysis
- 9.7 Quest Diagnostics Incorporated
- 9.7.1 Company Overview
- 9.7.2 Financial Analysis
- 9.7.3 Segmental Analysis
- 9.7.4 SWOT Analysis
- 9.8 Revvity, Inc.
- 9.8.1 Company Overview
- 9.8.2 Financial Analysis
- 9.8.3 Segmental and Regional Analysis
- 9.8.4 Research & Development Expenses
- 9.8.5 Recent strategies and developments:
- 9.8.5.1 Acquisition and Mergers:
- 9.8.6 SWOT Analysis
- 9.9 Eurofins Scientific SE
- 9.9.1 Company Overview
- 9.9.2 Financial Analysis
- 9.9.3 Regional Analysis
- 9.9.4 SWOT Analysis
- 9.10. Hologic, Inc.
- 9.10.1 Company Overview
- 9.10.2 Financial Analysis
- 9.10.3 Segmental and Regional Analysis
- 9.10.4 Research & Development Expenses
- 9.10.5 Recent strategies and developments:
- 9.10.5.1 Acquisition and Mergers:
- 9.10.6 SWOT Analysis
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook